Description

(11Bs)-2,6-Bis[3,5-Bis(Trifluoromethyl)Phenyl]Dinaphtho[2,1-D:1′,2′-F][1,3,2]Dithiazepine 3,3,5,5-Tetraoxide is a sophisticated, high-purity organic compound featuring a complex polycyclic structure with multiple trifluoromethyl groups. This compound is valued for its unique electronic and steric properties, making it a critical advanced intermediate in the synthesis of specialized materials and pharmaceuticals. It is primarily utilized by R&D chemists and process development scientists in the pharmaceutical, agrochemical, and advanced materials sectors for developing next-generation products.

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly for targeted therapies.
• Organic Light-Emitting Diode (OLED) Materials: Serves as a core component or dopant in the development of high-efficiency electron transport or host materials for display and lighting technologies.
• Ligand in Catalysis: Used to create specialized ligands for transition metal catalysts, enabling challenging cross-coupling and other asymmetric transformations.
• Agrochemical Research: Intermediate for developing new generation pesticides and herbicides with enhanced efficacy and environmental profiles.
• Advanced Polymer Synthesis: Monomer for creating high-performance, fluorinated polymers with exceptional thermal stability and chemical resistance.
• Material Science Research: Investigated for use in organic semiconductors, non-linear optical materials, and other functional materials.

Basic Information

Product Name	(11Bs)-2,6-Bis[3,5-Bis(Trifluoromethyl)Phenyl]Dinaphtho[2,1-D:1′,2′-F][1,3,2]Dithiazepine 3,3,5,5-Tetraoxide
CAS No.	1242421-77-7
Molecular Formula	C38H16F12N2O4S2
Molecular Weight	856.66 g/mol
Synonyms	2,6-Bis[3,5-bis(trifluoromethyl)phenyl]dinaphtho[2,1-d:1',2'-f][1,3,2]dithiazepine 3,3,5,5-tetraoxide; Dinaphtho[2,1-d:1',2'-f][1,3,2]dithiazepine-2,6-diylbis[3,5-bis(trifluoromethyl)benzene] 3,3,5,5-tetraoxide; (11Bs)-isomer of the above; Bis-CF3 Dithiazepine Tetraoxide Derivative; CAS 1242421-77-7; 1242421-77-7
EINECS	Contact for details

Quality Control

Our production of (11Bs)-2,6-Bis[3,5-Bis(Trifluoromethyl)Phenyl]Dinaphtho[2,1-D:1′,2′-F][1,3,2]Dithiazepine 3,3,5,5-Tetraoxide adheres to stringent quality management systems. Every batch is characterized and purified using advanced techniques like preparative HPLC and recrystallization to ensure exceptional purity and isomer consistency. Comprehensive analytical data, including NMR, HPLC, and MS, is provided. Certificates of Analysis (COA) detailing purity, identity, and impurity profiles are available upon request to support your regulatory and R&D documentation.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). The compound should be handled under an inert atmosphere if prolonged exposure is anticipated during use to maintain stability.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (HPLC)	Retention time corresponds to reference standard
Identification (NMR)	Spectrum consistent with structure
Purity (HPLC)	≥ 97.0% (Area Percent)
Isomeric Purity	≥ 95.0% (11Bs-isomer by HPLC)
Water Content (KF)	≤ 0.5% w/w
Residual Solvents (GC)	Complies with ICH Q3C guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.